Results 11 to 20 of about 4,916 (258)

Remimazolam for anaesthesia or sedation [PDF]

Current Opinion in Anaesthesiology, 2020
Purpose of review Anaesthesia and sedation are ubiquitous in contemporary medical practice. Developments in anaesthetic pharmacology are targeted on reducing physiological disturbance whilst maintaining or improving titrateability, recovery profile and patient experience.
J Robert, Sneyd, Ann E, Rigby-Jones
openaire   +4 more sources

Anesthesia Management of a Liver Transplant Recipient with Remimazolam

Case Reports in Anesthesiology, 2023
Background. Intraoperative anesthetic requirements might be altered due to the modulated metabolic function in living donor liver transplant recipients. Remimazolam may provide appropriate anesthesia in patients with cirrhosis.
Takashi Kawasaki, Takafumi Oyoshi, Naoyuki Hirata   +2 more
doaj   +2 more sources

Remimazolam Ameliorates Autistic‐Like Behaviors via Suppression of Ferroptosis in VTA Dopaminergic Neurons in a Mouse Model of ASD

Advanced Science
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, characterized by social dysfunction and stereotypic behavior, with the neuronal excitation/inhibition (E/I) imbalance as an underlying mechanism.
Yuxin Zhang, Jianwei Lin, Chaoyang Tong, Xin Fu, Mengqin Shan, Yue Huang, Kan Zhang, Jijian Zheng   +7 more
doaj   +2 more sources

Clinical Pharmacokinetics and Pharmacodynamics of Remimazolam

Clinical Pharmacokinetics
Remimazolam is a benzodiazepine with a high affinity for the γ-aminobutyric acid type A-receptor thereby inducing sedation and amnesia. It is a short-acting drug, has a fast onset, short duration of action, and a predictable recovery profile. Remimazolam
B. de Jong, D. Eleveld, K. Mason, M. Struys   +3 more
semanticscholar   +3 more sources

Efficacy and Safety of Remimazolam in Endoscopic Sedation—A Systematic Review and Meta-Analysis [PDF]

Frontiers in Medicine, 2021
Background: The aim of this systematic review and meta-analysis was to investigate the efficacy and safety of remimazolam in clinical endoscopic procedure sedation.Methods: The authors searched the databases of PubMed, Embase, and Cochrane Library for ...
Xianlin Zhu, Hongbai Wang, Su Yuan, Yinan Li, Yuan Jia, Zhe Zhang, Fuxia Yan, Zaiping Wang   +7 more
doaj   +2 more sources

Remimazolam: First Approval

Drugs, 2020
Remimazolam (Anerem® in Japan; ByFavo™ in the USA; Aptimyda™ in the EU) is an ultra-short-acting intravenous (IV) benzodiazepine sedative/anesthetic being developed by PAION AG in conjunction with a number of commercial partners for use in anesthesia and procedural sedation.
Susan J. Keam (6594447)
openaire   +3 more sources

Comparison of the anesthetic effects of remimazolam tosilate and remimazolam besylate in daytime hysteroscopic surgery

BMC Anesthesiology
Objective The purpose of this study is to observe whether there is a difference in the anesthetic effect of remimazolam tosilate and remimazolam besylate in daytime hysteroscopic surgery, so as to provide reference for clinical application. Methods Fifty
Huan Zhang, Min Fu, Fangli Yue, Yaxin Wei, Xinyuan Shi, Shiyu Yu, Fanceng Ji   +6 more
doaj   +3 more sources

Remimazolam for Zephyr Endobronchial Valve Placement in a Severe Chronic Obstructive Pulmonary Disease Patient: A Case Report. [PDF]

Clin Case Rep
ABSTRACT Remimazolam‐based general anesthesia provided stable hemodynamics and rapid, clear emergence in a patient with severe chronic obstructive pulmonary disease undergoing Zephyr endobronchial valve placement, suggesting that remimazolam may be a feasible anesthetic option for this procedure in patients with limited cardiopulmonary reserve.
Morimoto T, Ichinomiya T, Tobinaga S, Kaneko S, Sekino M, Murata H, Fukahori S, Hara T.   +7 more
europepmc   +2 more sources

Mapping the Clinical Evidence on Remimazolam in Anaesthesia: A Protocol for a Scoping Review. [PDF]

Acta Anaesthesiol Scand
ABSTRACT Background Remimazolam is a recently introduced benzodiazepine used for procedural sedation and general anaesthesia. Its pharmacokinetic profile, including rapid metabolism and predictable recovery, has generated interest in its potential advantages compared with traditional sedatives such as midazolam and propofol.
Nilsson EHVS, Abood I, Møller AM.
europepmc   +2 more sources

Remimazolam-induced intracellular calcium elevation.

, 2022
(A) An example of a typical remimazolam-induced intracellular calcium elevation time series in HUVECs. Approximately one min after the administration of 300 μM remimazolam, an increase in the fluorescence intensity of Fluo-4 was observed, indicating that
Soma Noguchi (12029730), Soshi Narasaki (12029724), Yasuo M. Tsutsumi (12029733), Norio Sakai (185474), Kazue Uchida (12029727), Yuhki Yanase (3960317), Tomoaki Urabe (12029718), Hirotsugu Miyoshi (12029721), Michihiro Hide (3960314)   +8 more
core   +1 more source